Results 151 to 160 of about 178,423 (263)
Masquerading Venous Thrombosis
openaire +2 more sources
Surgical Treatment of Lateral Skull Base Tumors Extending to the Craniovertebral Junction
ABSTRACT Objective To evaluate the clinical manifestation, surgical strategies, and long‐term outcomes of lateral skull base tumors extending to the craniovertebral junction (CVJ), with a focus on the infratemporal fossa approach (IFA) and individualized treatment options for cervical‐occipital stability.
Songbo Xue +14 more
wiley +1 more source
Hypoxia-inducible factors contribute to venous thrombosis in a mouse model of myeloproliferative neoplasms. [PDF]
Ghosh S +6 more
europepmc +1 more source
ABSTRACT Background Low‐flow vascular malformations (LFVMs) of the head and neck, including venous and lymphatic malformations, represent a heterogeneous group of congenital anomalies frequently requiring intervention due to functional and esthetic impairment.
Riccardo Nocini +6 more
wiley +1 more source
Superficial Venous Thrombosis in Non-Varicose Veins: A Narrative Review. [PDF]
Mangiafico M, Di Pino FL, Costanzo L.
europepmc +1 more source
ABSTRACT Background The robotic‐assisted extended “Sistrunk” approach (RESA) is a minimally invasive technique providing access to hypopharyngeal and laryngeal structures via a submental incision and vallecular pharyngotomy, bypassing the base of tongue.
Bartosz Wojtera +5 more
wiley +1 more source
Betrixaban for Deep Venous Thrombosis Prevention in a Patient with End-Stage Renal Disease on Intermittent Hemodialysis. [PDF]
Stevens VM, Furnish CJ, Kiser TH.
europepmc +1 more source
Cerebral Venous Thrombosis in Previously Healthy Patients with Cryptococcal Meningitis. [PDF]
Anjum SH +12 more
europepmc +1 more source
The impact of symptom duration on D-dimer: results from the Venous Thrombosis Registry in Østfold Hospital. [PDF]
Tavoly M +4 more
europepmc +1 more source
Among 568 mechanical heart valve replacement patients in Bangladesh, hemorrhagic stroke occurred in 4.4% with 52% mortality. Severe pulmonary hypertension increased risk 4.4‐fold, and warfarin therapy ≥104 months nearly doubled the risk, highlighting the need for long‐term risk monitoring in anticoagulated valve patients.
Dipannita Adhikary +10 more
wiley +1 more source

